TrialPH94B Nasal Spray for Anxiety Induced by a Public Speaking Challenge
Trial details
- Registry ID
- NCT04754802
- Phase
- Phase 3
Drug research
PH94B Nasal Spray
Open a linked trial to see its study details and recorded changes, or check the regulatory events below and follow their sources.
Drug identity checked against registry records
A drug appearing in a clinical trial does not mean it is FDA-approved. Check the original regulatory source for any approval claim.
Included trials
| Trial | Sponsor | Phase | Status | Primary completion |
|---|---|---|---|---|
| PH94B Nasal Spray for Anxiety Induced by a Public Speaking ChallengeNCT04754802 | VTGN | Phase 3 | Completed | 2022-06-22Actual |
| PH94B Nasal Spray for Anxiety Induced by a Public Speaking Challenge - 2NCT05011396 | VTGN | Phase 3 | Terminated | 2022-08-16Actual |
PH94B Nasal Spray for Anxiety Induced by a Public Speaking Challenge - 2
Trial details
- Registry ID
- NCT05011396
- Phase
- Phase 3
Regulatory dates and decisions
| No regulatory events match this view.Try another date range or view. Events appear after automated source checks. This does not mean no FDA events have occurred. Dates that a source does not disclose stay undisclosed. |